Results 221 to 230 of about 37,485,858 (384)

Reduction in menopause symptom severity following a personalised app-based dietary intervention program: a pre-post longitudinal analysis of the ZOE PREDICT 3 study [PDF]

George Pounis, Kate Bermingham, Joan Capdevila Pujol, William J. Bulsiewicz, Ana Roomans, Alice Creedon, Federica Amati, Jonathan Wolf, Tim D. Spector, Wendy L. Hall, Sarah Berry   +10 more
openalex   +1 more source

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

Molecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia, Noelia Moares, Wenjie Yi‐He, Rosa Luna‐Espejo, Ricardo Fernandez‐Cisnal, Javier Ocaña‐Cuesta, Juan P. Muñoz‐Miranda, Antonio Gabucio, Cecilia M. Fernandez‐Ponce, Francisco Garcia‐Cozar   +9 more
wiley   +1 more source

Trends in continuity of treatment among children and adolescents living with HIV in 14 districts in South Africa from 2018-2023: A retrospective program analysis. [PDF]

IJID Reg
Mugisa B, Kehoe K, Silere-Maqetseba T, Mabasa H, Golin R, Chehab J, Vrazo A, Srivastava M.   +7 more
europepmc   +1 more source

Development and validation of a helical coil heat exchanger model based on a system analysis program [PDF]

Zhen Lu, Ge Li, Zhanfei Qi, Jianqiang Shan, X Zhao, Zijiang Yang, 子江 杨   +6 more
openalex   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

Molecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz, Anna L. Bartkowiak, Michael Rose, Nora Kolks, Patrick Petzsch, Vandana Solanki, Anne Stoffel, Bianca Faßbender, Leandra Lepping, Julka Volkamer, Karl Köhrer, Marc Seifert, Tokameh Mahmoudi, Tahlita C. M. Zuiverloon, Günter Niegisch, Michèle J. Hoffmann   +15 more
wiley   +1 more source

Post-operative morbidity after neoadjuvant chemotherapy and resection for gallbladder cancer: A national surgical quality improvement program analysis. [PDF]

World J Gastrointest Surg
Kim M, Stroever S, Aploks K, Ostapenko A, Dong XD, Seshadri R.   +5 more
europepmc   +1 more source

Adverse Events After Microvascular Decompression: A National Surgical Quality Improvement Program Analysis. [PDF]

World Neurosurg, 2019
Cote DJ, Dasenbrock HH, Gormley WB, Smith TR, Dunn IF.   +4 more
europepmc   +1 more source

Joint Center Movement Analysis and 3D Motion Modeling of Upper Arm - Comparison of Several Algorithms with the Visual 3-D Program

, 2005
Leena Dennis Joseph
openalex   +2 more sources

Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway

Molecular Oncology, EarlyView.
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed, Kerstin Huebner, Katharina Erlenbach‐Wuensch, Chuanpit Hampel, Daniela Thalheim, Adriana Vial‐Roehe, Bodee Nutho, Susanne Merkel, Arndt Hartmann, Pithi Chanvorachote, Regine Schneider‐Stock   +10 more
wiley   +1 more source

Morbid Obesity and Diabetes Increase the Risk of Reoperation following Microvascular Decompression: A National Surgical Quality Improvement Program Analysis of 1,303 Patients. [PDF]

J Neurol Surg B Skull Base
Dincer A, Tabor JK, Pappajohn AF, O'Brien J, Morales-Valero S, Kim M, Moliterno J.   +6 more
europepmc   +1 more source